Hanik KholidahFor many patients, successfully completing primary breast cancer treatment marks the end of a grueling physical and emotional marathon. Yet, even after successful surgeries, chemotherapy regimens, and radiation therapies, an…
Susilo Wagino MulyoThe landscape of obesity and sleep medicine has undergone a significant transformation with the rise of glucagon-like peptide-1 receptor agonists (GLP-1s). Medications like Ozempic, Wegovy, and Zepbound have moved to…
Susilo Wagino MulyoThe landscape of obesity treatment has been fundamentally altered by the emergence of glucagon-like peptide-1 receptor agonists (GLP-1s). As clinical data continues to demonstrate a strong correlation between significant weight…
Susilo Wagino MulyoThe landscape of obesity and sleep medicine is undergoing a significant transformation as glucagon-like peptide-1 receptor agonists (GLP-1s) move to the forefront of clinical discussion. For the millions of adults…
Susilo Wagino MulyoThe intersection of weight management and sleep health has become a focal point of modern internal medicine, particularly as the prevalence of obstructive sleep apnea (OSA) continues to climb in…
Hanik KholidahThe rising frequency of high-profile foodborne illness outbreaks has intensified public concern regarding the safety of the global food supply chain and the subsequent medical interventions required to treat infections.…
Susilo Wagino MulyoThe landscape of treating obstructive sleep apnea (OSA), a pervasive condition affecting millions globally, is undergoing a significant transformation with the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists. While medications…
Susilo Wagino MulyoThe landscape of treating Obstructive Sleep Apnea (OSA) is undergoing a significant transformation with the emergence of Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications initially developed for type…
Hanik KholidahThe landscape of modern psychiatry is facing a potential paradigm shift as new clinical data suggests that the long-standing model of daily pharmacological intervention for depression may eventually be supplemented,…
Susilo Wagino MulyoThe treatment paradigm for obstructive sleep apnea (OSA) is undergoing a significant transformation with the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications initially developed for type…
